Concepedia

Brenda J. Schmieder

BJ

Statistics

Publications

3

Citations

214

H-Index

3

Active since

1994

Affiliations

Pfizer (United States)(Current)

Brenda J. Schmieder is an author at Pfizer (United States) specializing in drug discovery, life sciences, and bacteriostatic activity.

Publications per year

1994–1996

3

Publications

3

Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro

Thomas D. Gootz, Richard P. Zaniewski, S L Haskell et al. · Antimicrobial Agents and Chemotherapy · 1996 · 137 citations · Full text

, , +17

In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial

Thomas D. Gootz, Katherine E. Brighty, Marge R. Anderson et al. · Diagnostic Microbiology and Infectious Disease · 1994 · 41 citations

, , +8

Assays to Detect and Characterize Synthetic Agents that Inhibit the ErmC Methyltransferase.

Joanna Clancy, Brenda J. Schmieder, J.W. Petitpas et al. · The Journal of Antibiotics · 1995 · 36 citations · Full text

, , +12

1–3 of 3